The dysregulation of the miR-15a and miR-16-1 cluster involves multiple oncogenic phenotypes such as cell survival, proliferation, and invasion by directly targeting CCND1 (cyclin D1), WNT3A, and BCL2, evident in prostate and pancreatic cancers. Here, CCND1 is linked to familial pancreatic carcinoma.